AI-Native Guided Imagery Therapeutics

Turning guided imagery into a scalable clinical intervention

TederHealth transforms a clinically validated mind-body therapy into a measurable, protocol-driven digital therapeutic - generating personalized therapeutic audio and delivering it across hospital and home settings.

600+
Active users in our live technical proof-of-concept
RCT
Investigator-initiated trial in preparation with a leading top-100 hospital
Decades
Of peer-reviewed clinical evidence behind guided imagery
$30B+
Digital therapeutics market by 2030
The problem

Strong evidence. No delivery infrastructure.

Guided imagery is supported by decades of peer-reviewed evidence across many clinical settings. Yet it has never been translated into a scalable, measurable, clinical-grade therapeutic system. Today its delivery remains fragmented.

Practitioner-led sessions - non-scalable and inconsistent across patients and sites.
Static content - generic, non-personalized, and non-adaptive to the patient's clinical context.
Despite strong clinical evidence, guided imagery has not become a reimbursable digital therapeutic or a standardized clinical tool.
The solution

An AI-native digital therapeutics platform

We generate personalized, protocol-driven therapeutic audio based on clinical diagnosis, treatment stage, patient profile, and continuous feedback - delivered digitally with limited clinician involvement after enrollment.

1

Clinical inputs

Diagnosis, treatment stage, and patient profile define the therapeutic protocol.

2

AI personalization

The system generates tailored, protocol-driven therapeutic audio for each patient.

3

Digital delivery

Sessions are delivered across hospital and home settings for continuous support.

4

Feedback loop

Continuous patient feedback adapts the protocol and produces measurable outcomes.

Therapeutic audio, personalized to each patient

Continuous mind-body support - in the hospital and at home.

The science

What guided imagery is - and why it works

Guided imagery is a structured mind-body technique that uses directed, multisensory mental imagery to influence physiological and psychological states. Decades of research show the brain treats vividly imagined experience much like real experience - which is what gives the practice its therapeutic power.

🧠

Imagined ≈ real, to the brain

Vividly imagined actions and scenes activate many of the same sensory, motor, and autonomic neural circuits as the real experience. Mental rehearsal engages the brain much like genuine practice does.

🔗

Neuroplasticity - repetition rewires

Structured, repeated imagery strengthens neural pathways - "neurons that fire together wire together." Consistent practice can drive lasting functional change, similar to physical training.

🫀

Mind-body regulation

Imagery shifts the autonomic nervous system toward calm - lowering stress arousal, modulating how pain is processed, and supporting the body's own regulatory and healing mechanisms.

This scientific basis is reflected in the clinical outcomes documented across decades of peer-reviewed studies (below).

Evidence base

Clinically validated, across multiple domains

Guided imagery is supported across multiple clinical domains, with evidence of measurable benefit. The clinical efficacy is well established - what has been missing is the infrastructure to deliver it at scale.

Length of hospital stay Pharmaceutical utilization Pain & anxiety scores Treatment adherence Patient-reported outcomes
🧠

Mind-body therapy

A non-pharmacological intervention with decades of peer-reviewed support.

📊

Measurable

Designed to produce structured, protocol-level outcome data.

🏥

Clinically integrable

Built to fit real hospital and home care workflows.

💊

Reimbursable path

Aiming at a recognized, reimbursable digital therapeutic category.

Selected peer-reviewed research

A sample of the independent, published evidence on guided imagery as a clinical intervention. These are third-party studies - not conducted by TederHealth and not evaluations of our platform. They illustrate the established clinical basis our technology is built to deliver at scale.

~$2,003 / Procedure

A payer-delivered presurgical program (905 health-plan members) cut pharmacy costs and total billed charges by 14% each - about $2,003 saved per procedure - alongside reduced anxiety and high satisfaction.

Schwab et al., Advances in Mind-Body Medicine, 2007 · PubMed
−43% Opioid Use

A randomized controlled trial in colorectal surgery: total opioid use fell from 326 mg to 185 mg, with less pain and anxiety, faster recovery, and higher patient satisfaction.

Tusek et al., Diseases of the Colon & Rectum, 1997 · PubMed
↓ Stay & Costs

A cardiac-surgery program reported shorter average length of stay and lower pharmacy and pain-medication costs, while maintaining high patient satisfaction.

Halpin et al., Outcomes Management, 2002 · PubMed
Meta-Analysis

A pooled analysis of randomized trials found preoperative guided imagery significantly reduces anxiety and postoperative pain - "an effective, easy and low-cost intervention."

Álvarez-García & Şimşek Yaban, Complementary Therapies in Clinical Practice, 2020 · PubMed
Traction & clinical pipeline

From proof of concept to clinical validation

Proof of concept

600+ active users acquired through paid ads, each receiving 100% AI-generated, personalized guided imagery - two sessions per week via WhatsApp, with real-time engagement tracking. A non-clinical deployment proving the technology works at scale.

🔬

Clinical development

Investigator-initiated randomized controlled trial in preparation in labor & delivery, with a leading hospital in Israel ranked among the world's top 100.

🤝

Clinical discussions

Early-stage engagements underway with leading Israeli health systems.

Applicable across the full spectrum of care
Oncology Cardiac Obstetric Pediatric Neurologic Orthopedic Gastrointestinal Gynecologic Urologic Renal / Nephrology Critical Care / ICU Presurgical Burns / Wound Care Dental Psychiatric
Modern hospital interior

Built for real clinical settings

Designed to integrate into hospital and home care pathways.

Market opportunity

A category becoming inevitable

$30B+

Digital therapeutics is a rapidly growing global healthcare category, projected to exceed $30B by 2030 (Grand View Research). Pressure to cut cost of care, improve outcomes, and reduce reliance on pharmacology is making AI-native, scalable digital therapeutics inevitable.

Hospital systems Payers Integrated care pathways
Team

Bridging AI systems and clinical mind-body therapeutics

A founder combining deep technical execution with hands-on guided imagery practice, backed by senior clinical and regulatory advisory.

Ron Adany, PhD

Founder & CEO

A serial entrepreneur who has founded and led multiple startups across fintech, e-commerce, and wellness - backed by a PhD in Computer Science. Ron is also an active guided imagery therapist (certified, Wingate Institute) treating patients with diagnosed physical conditions at his own clinic, with a strong track record of documented results and patient success stories - a rare blend of AI systems builder and hands-on clinician.

His own story: Ron's path into this field began with a personal health challenge he worked through using guided imagery - a measurable recovery that surprised his doctors. That experience led him to practice professionally and, ultimately, to build TederHealth so this evidence-based approach can reach patients at scale.

Member, The Israeli Society for Complementary and Integrative Medicine
LinkedIn →

Tsvia Erlich

Clinical Trial & Regulatory Advisor

Regulatory & clinical-affairs leader with 25+ years in life sciences (medical devices & IVD), including VP roles at startups and international healthcare companies. She has driven regulatory strategies that won market clearance across the EU, USA, South America and Japan, and designed and run multinational, multi-site clinical trials.

Founder of N.G.I.T Premium Consulting, supporting 70+ medical-device companies across quality systems, design control, and FDA / notified-body submissions (510(k), De Novo, Technical File). She advises TederHealth on clinical-trial design, endpoints and statistics, and Helsinki / IRB compliance.

LinkedIn →

Get in touch

Partner with us on a clinical pilot

Engaging hospital systems, payers, and research partners. Let's explore a pilot or collaboration.

We'll email you a confirmation and get back to you shortly.